These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24869799)

  • 1. Body mass index, diabetes, and triple-negative breast cancer prognosis.
    Tait S; Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
    Breast Cancer Res Treat; 2014 Jul; 146(1):189-97. PubMed ID: 24869799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and weight change in relation to triple-negative breast cancer survival.
    Bao PP; Cai H; Peng P; Gu K; Su Y; Shu XO; Zheng Y
    Cancer Causes Control; 2016 Feb; 27(2):229-36. PubMed ID: 26621544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does obesity have an effect on outcomes in triple-negative breast cancer?
    Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
    J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
    Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
    J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Body Mass Index in Triple Negative Breast Cancer.
    Cakar B; Muslu U; Erdogan AP; Ozisik M; Ozisik H; Tunakan Dalgic C; Durusoy R; Karaca B; Sezgin C; Karabulut B; Uslu R
    Oncol Res Treat; 2015; 38(10):518-22. PubMed ID: 26452262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
    Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
    Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
    Widschwendter P; Friedl TW; Schwentner L; DeGregorio N; Jaeger B; Schramm A; Bekes I; Deniz M; Lato K; Weissenbacher T; Kost B; Andergassen U; Jueckstock J; Neugebauer J; Trapp E; Fasching PA; Beckmann MW; Schneeweiss A; Schrader I; Rack B; Janni W; Scholz C
    Breast Cancer Res; 2015 Sep; 17(1):129. PubMed ID: 26385214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
    Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
    Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158.
    Ballinger TJ; Jiang G; Kassem N; Radovich M; Schneider BP
    Clin Cancer Res; 2021 Feb; 27(4):1195-1199. PubMed ID: 33199491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression in triple-negative breast cancer in relation to survival.
    Wang S; Beeghly-Fadiel A; Cai Q; Cai H; Guo X; Shi L; Wu J; Ye F; Qiu Q; Zheng Y; Zheng W; Bao PP; Shu XO
    Breast Cancer Res Treat; 2018 Aug; 171(1):199-207. PubMed ID: 29748761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.
    Tung N; Gaughan E; Hacker MR; Lee LJ; Alexander B; Poles E; Schnitt SJ; Garber JE
    Breast Cancer Res Treat; 2014 Jul; 146(1):175-82. PubMed ID: 24839033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
    Lara-Medina F; Pérez-Sánchez V; Saavedra-Pérez D; Blake-Cerda M; Arce C; Motola-Kuba D; Villarreal-Garza C; González-Angulo AM; Bargalló E; Aguilar JL; Mohar A; Arrieta Ó
    Cancer; 2011 Aug; 117(16):3658-69. PubMed ID: 21387260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-negative breast cancer: An institutional analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
    Indian J Cancer; 2014; 51(2):163-6. PubMed ID: 25104201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors and patterns of recurrence in patients with triple negative breast cancer.
    Steward L; Conant L; Gao F; Margenthaler JA
    Ann Surg Oncol; 2014 Jul; 21(7):2165-71. PubMed ID: 24558065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of overweight and obesity in a breast clinic population: consideration for weight loss as a therapeutic intervention.
    Kim A; Scharf K; Senthil M; Solomon N; Garberoglio C; Lum SS
    Surg Obes Relat Dis; 2014; 10(2):348-53. PubMed ID: 24094868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.
    Ladoire S; Dalban C; Roché H; Spielmann M; Fumoleau P; Levy C; Martin AL; Ecarnot F; Bonnetain F; Ghiringhelli F
    Eur J Cancer; 2014 Feb; 50(3):506-16. PubMed ID: 24315625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
    Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
    Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.